Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

464.50p
   
  • Change Today:
      6.00p
  • 52 Week High: 464.50
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.20m
  • Volume: 269,359
  • Market Cap: £493.30m
  • RiskGrade: 125
  • Beta: 0.02

Latest ShareCast News

Oxford Biomedica agrees new four-year, $125m loan facility

By Josh White

Date: Friday 01 Aug 2025

(Sharecast News) - Oxford Biomedica announced on Friday that it has agreed a new four-year loan facility of up to $125m with Oaktree Capital Management, refinancing its existing debt and providing additional funding capacity to support future expansion.

Oxford Biomedica flags sharp rise in first-half revenue

By Josh White

Date: Monday 28 Jul 2025

(Sharecast News) - Oxford Biomedica reported a sharp rise in first-half revenue and strong commercial momentum on Monday, as it reiterated its full-year guidance and pointed to growing demand across its cell and gene therapy manufacturing platforms.

Oxford Biomedica acquires last 10pc stake in US subsidiary

By Josh White

Date: Monday 23 Jun 2025

(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.

Oxford Biomedica reports first-half revenue growth 23-Sep-2024 ShareCast
Oxford Biomedica still expecting small loss afte... 08-Aug-2024 ShareCast
Oxford Biomedica appoints new finance chief 17-Jul-2024 ShareCast
Oxford Biomedica confident as it moves away from... 29-Apr-2024 ShareCast
Oxford Biomedica shares rise on post-acquisition... 05-Mar-2024 ShareCast
Director dealings: TUI, Oxford Biomedica board m... 27-Sep-2023 ShareCast
Liberum cuts target price for Oxford Biomedica, ... 28-Nov-2022 ShareCast
Oxford Biomedica taps Frank Mathias as its new CEO 22-Nov-2022 ShareCast
Oxford Biomedica swings to loss as Covid vaccine... 15-Sep-2022 ShareCast
Oxford Biomedica inks LSA with new US biotech pa... 07-Sep-2022 ShareCast
Oxford Biomedica inks LSA with US biotech firm, ... 26-Jul-2022 ShareCast
Oxford Biomedica signs new Covid vaccine deal wi... 01-Jul-2022 ShareCast
Oxford Biomedica sees FDA lift clinical hold on ... 14-Jun-2022 ShareCast
Oxford Biomedica posts good growth, notes pause ... 20-Apr-2022 ShareCast
Oxford Biomedica's Parkinson's licensee pulls out 01-Feb-2022 ShareCast
Oxford Biomedica creates venture with Homology, ... 28-Jan-2022 ShareCast
Oxford Biomedica CEO John Dawson to step down 17-Jan-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 464.50p
Change Today 6.00p
% Change 1.31 %
52 Week High 464.50
52 Week Low 232.50
Volume 269,359
Shares Issued 106.20m
Market Cap £493.30m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.44% below the market average32.44% below the market average32.44% below the market average32.44% below the market average32.44% below the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Price Trend
53.87% above the market average53.87% above the market average53.87% above the market average53.87% above the market average53.87% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Income Not Available
Growth
4.65% above the market average4.65% above the market average4.65% above the market average4.65% above the market average4.65% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
17:08 1,700 @ 464.50p
16:35 30,180 @ 464.50p
16:35 8 @ 464.50p
16:35 15 @ 464.50p
16:35 797 @ 464.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page